Literature DB >> 7884096

Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators.

N el-Sherif1, P Denes, R Katz, R Capone, L B Mitchell, M Carlson, R Reynolds-Haertle.   

Abstract

OBJECTIVES: The goal of this study was to establish guidelines for the prognostic use of the time domain signal-averaged electrocardiogram (ECG) after myocardial infarction.
BACKGROUND: Previous studies of the prognostic use of the signal-averaged ECG in postinfarction patients had one or more of the following limitations: a small study group, empiric definition of an abnormal recording and possible bias in the selection of high risk groups or classification of arrhythmic events, or both. To correct for these limitations, a substudy was conducted in conjunction with the Cardiac Arrhythmia Suppression Trial (CAST).
METHODS: Ten centers recruited 1,211 patients with acute myocardial infarction without application of the ejection fraction or Holter criteria restrictions of the main CAST protocol. Several clinical variables, ventricular arrhythmias on the Holter recording, ejection fraction and six signal-averaged ECG variables were analyzed. Patients with bundle branch block were excluded from the analysis, and the remaining 1,158 were followed for up to 1 year after infarction. The classification of arrhythmic events was reviewed independently by the CAST Events Committee.
RESULTS: During an average (+/- SD) follow-up of 10.3 +/- 3.2 months, 45 patients had a serious arrhythmic event (nonfatal ventricular tachycardia or sudden cardiac arrhythmic death). A Cox regression analysis with only the six signal-averaged ECG variables indicated that the filtered QRS duration at 40 Hz > or = 120 ms (QRSD-40 Hz) at a cutpoint > or = 120 ms was the most predictive criterion of arrhythmic events. In a regression analysis that included all clinical, Holter and ejection fraction variables, a QRSD-40 Hz > or = 120 ms was the most significant predictor (p < 0.0001). The positive, negative and total predictive accuracy and odds ratio for QRSD-40 Hz > or = 120 ms were 17%, 98%, 88% and 8.4, respectively, and improved to 32%, 97%, 94% and 16.7, respectively, after combination with ejection fraction < or = 40% and complex ventricular arrhythmias on the Holter recording.
CONCLUSIONS: The signal-averaged ECG predicts serious arrhythmic events in the first year after infarction better than do clinical, ejection fraction and ventricular arrhythmia variables, and QRSD-40 Hz > or = 120 ms provides the best predictive criterion in this clinical setting.

Entities:  

Mesh:

Year:  1995        PMID: 7884096     DOI: 10.1016/0735-1097(94)00504-j

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  [Limitations and possibilities of noninvasive risk stratification for sudden cardiac death].

Authors:  Tobias Tönnis; Karl-Heinz Kuck
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

Review 2.  The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia.

Authors:  J A Gomes
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

3.  QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure.

Authors:  L Bode-Schnurbus; D Böcker; M Block; R Gradaus; A Heinecke; G Breithardt; M Borggrefe
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

4.  Nonischemic mitral regurgitation: prognostic value of nonsustained ventricular tachycardia after mitral valve surgery.

Authors:  Oladipupo Olafiranye; Clare A Hochreiter; Jeffrey S Borer; Phyllis G Supino; Edmund M Herrold; Adam S Budzikowski; Ofek Y Hai; Dany Bouraad; Paul D Kligfield; Leonard N Girardi; Karl H Krieger; O Wayne Isom
Journal:  Cardiology       Date:  2013-02-20       Impact factor: 1.869

5.  Effects of early losartan therapy on ventricular late potentials in acute myocardial infarction.

Authors:  Dae-Hyeok Kim; Woong-Gil Choi; Jun Kwan; Keum-Soo Park; Woo-Hyung Lee
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

Review 6.  Risk stratification and epidemiology of sudden death.

Authors:  Sri Sundaram; Jeffrey J Goldberger
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

7.  Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale.

Authors:  Yoshiaki Kubota; Takeshi Yamamoto; Shuhei Tara; Yukichi Tokita; Kenji Yodogawa; Yuki Iwasaki; Hitoshi Takano; Yayoi Tsukada; Kuniya Asai; Masaaki Miyamoto; Yasushi Miyauchi; Eitaro Kodani; Naoki Sato; Jun Tanabe; Wataru Shimizu
Journal:  Diabetes Ther       Date:  2018-08-10       Impact factor: 2.945

8.  A smartphone-assisted pressure-measuring-based diagnosis system for acute myocardial infarction diagnosis.

Authors:  Guolin Hong; Gang Rui; Dongdong Zhang; Mingjian Lian; Yuanyuan Yang; Ping Chen; Huijing Yang; Zhichao Guan; Wei Chen; Yan Wang
Journal:  Int J Nanomedicine       Date:  2019-04-08

9.  Combined evaluation of ambulatory-based late potentials and nonsustained ventricular tachycardia to predict arrhythmic events in patients with previous myocardial infarction: A Japanese noninvasive electrocardiographic risk stratification of sudden cardiac death (JANIES) substudy.

Authors:  Kenichi Hashimoto; Mari Amino; Koichiro Yoshioka; Yuji Kasamaki; Toshio Kinoshita; Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-09-24       Impact factor: 1.468

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.